Although the prevalence of AS in mainland China between 2005 and 2019 (0.22–0.35%) was lower than that in the United States (0.9–1.4% from 2009 to 2010) and that in central Europe (0.3–0.5% from 2000 to 2006), it has shown an increasing trend [ 1 , 2 , 6 ].
← all excerpts
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.
1
—
—